Goa-headquartered health-tech company Molbio Diagnostics Limited is set to launch its Initial Public Offering (IPO), marking a major milestone for the state’s innovation and manufacturing ecosystem. The company has fixed the IPO price band at ₹768 to ₹807 per equity share and will open bidding from August 10 to August 12, 2026.
Tag: Medical Technology
OptraSCAN Receives USFDA 510(k) Clearance for AI-Powered Digital Pathology System
OptraSCAN, the California-headquartered digital pathology company backed by Molbio Diagnostics, has received USFDA 510(k) clearance for its integrated digital pathology system, marking a major milestone in AI-driven cancer diagnostics and digital pathology innovation.
Victor Hospital Celebrates Goa’s First AI-Powered ROSA® Robotic Knee Replacement Success Stories
Victor Hospital and the Dhakankar Robotic Centres team celebrated the remarkable success of Goa's first AI-powered ROSA® Robotic Knee Replacement System by honouring patients whose lives have been transformed through advanced robotic-assisted surgery.
Molbio & UE LifeSciences Partner to Expand iBreastExam Globally for Early Breast Cancer Detection
Molbio Diagnostics and UE LifeSciences announce an exclusive collaboration to expand iBreastExam, a radiation-free, painless, and FDA-cleared breast health screening device, across India, Africa, the Middle East, and beyond. The partnership aims to bring accessible early detection to millions of women in over 50 countries.
Molbio Diagnostics Empowers Philippines to Fast-Track TB Elimination with Truenat and Ultra-Portable X-ray Tech
With over 190,000 undiagnosed TB cases annually, the Philippines is turning to Indian innovation to close the gap. Through Molbio Diagnostics' WHO-endorsed Truenat® systems and portable X-ray solutions, the country is enhancing its ability to screen, diagnose, and treat TB—especially in remote and underserved communities.